Latest Industry Insights

To learn about some of the main challenges associated with generating a large library of edited iPSCs and the role that Synthego is playing in the iNDI project, we spoke to Synthego’s CSO, Dr Robert Dean.

In this article, we outline how researchers at the University of Maastricht have used a novel spatial omics workflow to uncover proteomic profiles in tumor subpopulations of breast cancer.

Molecular Devices recently unveiled a brand new, first-of-its-kind Organoid Innovation Center. In this interview, Susan Murphy tells us more about the Center and discusses the advantages of automating organoid culturing and screening workflows.

In this interview, Dr George Emanuel discusses the power of spatial transcriptomic profiling and some of the biggest trends in the field.

We spoke to Dr Lorna Ewart, Emulate’s executive vice president of science, to learn more about the limitations of traditional inflammatory intestinal disease models, what makes the Colon Intestine-Chip a more relevant model and how it can be used to investigate potential drug targets.

In this interview, Dr Sudeb Dalai, senior medical director at Adaptive Biotechnologies, discusses the role that T-cell analysis may play in the diagnosis and treatment of diseases including SARS-CoV-2.

A new body of work published in Science Translational Medicine outlines the preclinical testing of a microRNA-based gene therapy for Huntington's disease – AMT-130 – in minipigs.

In this interview, Technology Networks spoke with Neal Goodwin, PhD, Chief Scientific Officer at Teknova, to learn more about current bioprocessing and bioproduction trends in the cell and gene therapy space. Goodwin also discusses the impact of the COVID-19 pandemic on the biopharmaceutical sector and highlights how the industry has united to contribute to the development of vaccines at this critical time.

Animal-free testing methods are being increasingly explored and implemented as an alternative to animal models, in efforts to provide a more accurate prediction of a drug candidate’s efficacy and safety. InSphero recently hosted a virtual roundtable discussion on the topic of animal-free testing. Technology Networks had the pleasure of speaking with Armin Wolf, chief scientific officer at InSphero, to learn more about the topics discussed.

Technology Networks recently had the pleasure of speaking to Seth Lederman, president and chief executive officer of Tonix Pharmaceuticals, to learn more about the T-cell response to SARS-CoV-2, how it compares to the antibody response and the importance of measuring it during the pandemic.